Serum Institute and RDIF plan to produce over 300 million doses of the Sputnik V vaccine in India per year. Serum Institute of India (SII) has entered into an agreement with Russia’s sovereign wealth ...
ETHealthworld.com brings latest panacea biotec news, views and updates from all top sources for the Indian Health industry.
DHAKA, April 27 (Reuters) - Bangladesh's drug regulator on Tuesday approved the Russian Sputnik V vaccine for emergency use against COVID-19, signalling that clearance for China's Sinopharm shot would ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results